Remimazolam and Remifentanil Anesthetics for an Adolescent Patient with Stiff-Person Syndrome: A Case Report

A A Pract. 2024 Feb 19;18(2):e01758. doi: 10.1213/XAA.0000000000001758. eCollection 2024 Feb 1.

Abstract

Stiff-person syndrome (SPS) is a rare autoimmune disease characterized by fluctuating rigidity and stiffness of the axial muscles. There are no reports on the use of remimazolam in a patient with SPS. A 16-year-old Japanese woman with SPS was scheduled to undergo intrathecal baclofen pump exchange. General anesthesia was induced and maintained using remimazolam, remifentanil, and intermittent rocuronium bromide. No intraoperative mobility or significant autonomic symptoms were observed. Additionally, electroencephalographic signature showed sufficient anesthetic depth. The patient's emergence from general anesthesia was uneventful. In conclusion, remimazolam could be considered an effective anesthetic drug for patients with SPS.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anesthesia, General
  • Anesthetics*
  • Benzodiazepines*
  • Female
  • Humans
  • Remifentanil
  • Stiff-Person Syndrome* / drug therapy
  • Stiff-Person Syndrome* / surgery

Substances

  • Remifentanil
  • remimazolam
  • Anesthetics
  • Benzodiazepines